Theodore F. Logan
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 39
- CAR-T cell therapy research 29
- Cutaneous Melanoma Detection and Management 7
- Immunology top 1%
- Immunotherapy and Immune Responses 24
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 18
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment 41
- Genetics top 2%
-
- Renal and related cancers 17
- Melanoma and MAPK Pathways 7
- Co-authors
- Kim MargolinDavid F. McDermottJanice P. DutcherMichael B. AtkinsJoseph I. ClarkMarc S. ErnstoffJohn M. KirkwoodIgor Puzanov
- Cited by
- OncologyImmunologyCancer Research
- Journals
- Journal of Clinical Oncology (44 papers)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Theodore F. Logan
119 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 4.5k
- Immunology 2.1k
- Cancer Research 1.5k
- Pulmonary and Respiratory Medicine 3.2k
- Genetics 597
Countries citing papers authored by Theodore F. Logan
This map shows the geographic impact of Theodore F. Logan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore F. Logan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore F. Logan more than expected).
Fields of papers citing papers by Theodore F. Logan
This network shows the impact of papers produced by Theodore F. Logan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore F. Logan. The network helps show where Theodore F. Logan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Theodore F. Logan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2021 | 18 | |
| 4 | 2021 | 15 | |
| 5 | Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibodybreakdown → | 2016 | 281 |
| 6 | 2016 | 311 | |
| 7 | Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trialbreakdown → | 2014 | 865 |
| 8 | 2014 | 201 | |
| 9 | 2014 | 12 | |
| 10 | 2011 | 83 | |
| 11 | 2010 | 150 | |
| 12 | A Phase 2 study of the dual MET/VEGFR2 inhibitor XL880 in patients (pts) with papillary renal carcinoma (PRC). | 2007 | 7 |
| 13 | 2007 | 4 | |
| 14 | 2005 | 106 | |
| 15 | Preliminary pharmacokinetic evaluation of Albuleukin; an interleukin-2 human serum albumin fusion protein, in solid tumor patients | 2004 | 9 |
| 16 | 2003 | 57 | |
| 17 | An investigation of the information seeking behaviour of medical oncologists in Metropolitan Pittsburgh using a multi-method approach | 1999 | 5 |
| 18 | An Investigation of the Information Seeking Behavior of Medical Oncologists in Metropolitan Pittsburgh Using a Multimethod Approach | 1997 | 1 |
| 19 | 1997 | 33 | |
| 20 | 1991 | 4 |
About Theodore F. Logan
Theodore F. Logan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 120 papers that have together received 8.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (41 papers), Cancer Immunotherapy and Biomarkers (39 papers), CAR-T cell therapy research (29 papers), Immunotherapy and Immune Responses (24 papers), Cancer Genomics and Diagnostics (18 papers), Renal and related cancers (17 papers), Melanoma and MAPK Pathways (7 papers) and Cutaneous Melanoma Detection and Management (7 papers). The work is most often cited by research in Oncology (4.5k citations), Immunology (2.1k citations) and Cancer Research (1.5k citations). Theodore F. Logan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Kim Margolin, David F. McDermott, Janice P. Dutcher, Michael B. Atkins, Joseph I. Clark, Marc S. Ernstoff, John M. Kirkwood, Igor Puzanov, Omid Hamid and F. Stephen Hodi. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.